Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis
暂无分享,去创建一个
M. Jorge Cardoso | Ferran Prados | Xavier Golay | Manuel Jorge Cardoso | Olga Ciccarelli | Frank Riemer | Marios Yiannakas | O. Ciccarelli | X. Golay | W. Brownlee | B. Solanky | F. Prados | M. Yiannakas | Patricia Alves Da Mota | F. Riemer | S. Ourselin | Claudia A. M. Gandini Wheeler-Kingshott | Wallace J Brownlee | Sebastian Ourselin | Bhavana Solanky | Patricia Da Mota | Claudia Gandini Wheeler-Kingshott | C. G. Gandini Wheeler-Kingshott
[1] Bertrand Audoin,et al. Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study. , 2012, Radiology.
[2] S. Reingold,et al. Defining the clinical course of multiple sclerosis , 1996, Neurology.
[3] David H. Miller,et al. Gray matter atrophy is related to long‐term disability in multiple sclerosis , 2008, Annals of neurology.
[4] Hillary C. M. Nelson. The National Adult Reading Test , 1982 .
[5] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[6] Hans Lassmann,et al. Progressive multiple sclerosis: pathology and pathogenesis , 2012, Nature Reviews Neurology.
[7] N. Larocca,et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.
[8] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[9] Sebastien Ourselin,et al. Automatic sodium maps reconstruction using PatchMatch algorithm for phantom detection , 2016 .
[10] L. Schad,et al. Increased total sodium concentration in gray matter better explains cognition than atrophy in MS , 2017, Neurology.
[11] D. Wade,et al. The Adult Memory and Information Processing Battery (AMIPB) test of information-processing speed: a study of its reliability and feasibility in patients with multiple sclerosis , 2003, Clinical rehabilitation.
[12] Tim Shallice,et al. The Hayling and Brixton Tests , 1997 .
[13] D. Bechtold,et al. Axonal protection using flecainide in experimental autoimmune encephalomyelitis , 2004, Annals of neurology.
[14] Xavier Golay,et al. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis. , 2013, Brain : a journal of neurology.
[15] Sébastien Ourselin,et al. Scale Factor Point Spread Function Matching: Beyond Aliasing in Image Resampling , 2015, MICCAI.
[16] A. Thompson,et al. Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis , 2002, Multiple sclerosis.
[17] C. Poser,et al. Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.
[18] Frederik Barkhof,et al. Grey matter pathology in multiple sclerosis , 2008, The Lancet Neurology.
[19] Lazar Fleysher,et al. Sodium MRI of multiple sclerosis , 2016, NMR in biomedicine.
[20] Lublin Fd,et al. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .
[21] Lazar Fleysher,et al. Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study. , 2016, Brain : a journal of neurology.
[22] Jia Newcombe,et al. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] Sébastien Ourselin,et al. A multi-time-point modality-agnostic patch-based method for lesion filling in multiple sclerosis , 2016, NeuroImage.
[24] B Stoeckel,et al. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. , 2010, Brain : a journal of neurology.
[25] O Ciccarelli,et al. Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome , 2017, Multiple sclerosis.
[26] E. D’Angelo,et al. Challenges and Perspectives of Quantitative Functional Sodium Imaging (fNaI) , 2018, bioRxiv.
[27] M. Calabrese,et al. Cortical lesion load associates with progression of disability in multiple sclerosis. , 2012, Brain : a journal of neurology.
[28] Roberto Mutani,et al. Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.
[29] R. Rudick,et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients , 2006, Annals of neurology.
[30] Stephen M. Rao,et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. , 1999, Brain : a journal of neurology.
[31] Bertrand Audoin,et al. Topography of brain sodium accumulation in progressive multiple sclerosis , 2014, Magnetic Resonance Materials in Physics, Biology and Medicine.
[33] David H. Miller,et al. Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial , 2016, The Lancet Neurology.
[34] Daniel Rueckert,et al. Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and Fusion , 2015, IEEE Transactions on Medical Imaging.
[35] X. Golay,et al. Sodium (23Na) ultra-short echo time imaging in the human brain using a 3D-Cones trajectory , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.
[36] A. Thompson,et al. Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis , 2009, Multiple sclerosis.